Lanraplenib

CAS No. 1800046-95-0

Lanraplenib( GS-9876 )

Catalog No. M23810 CAS No. 1800046-95-0

Lanraplenib is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 61 In Stock
5MG 91 In Stock
10MG 153 In Stock
25MG 275 In Stock
50MG 408 In Stock
100MG 600 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Lanraplenib
  • Note
    Research use only, not for human use.
  • Brief Description
    Lanraplenib is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases.
  • Description
    Lanraplenib is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases. Lanraplenib inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GS-9876
  • Pathway
    Angiogenesis
  • Target
    Syk
  • Recptor
    SYK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1800046-95-0
  • Formula Weight
    443.5
  • Molecular Formula
    C23H25N9O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:41.67 mg/mL (93.96 mM; Need ultrasonic)
  • SMILES
    C1CN(CCN1C2COC2)C3=CC=C(C=C3)NC4=NC(=CN5C4=NC=C5)C6=CN=CC(=N6)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Di Paolo J, et al. FRI0049 Preclinical Characterization of GS-9876, A Novel, Oral SYK Inhibitor That Shows Efficacy in Multiple Established Rat Models of Collagen-Induced Arthritis.Annals of the Rheumatic Diseases 2016;75:443-444.
molnova catalog
related products
  • RO9021

    RO9021 is an orally bioavailable, novel ATP-competitive SYK inhibitor (average IC50: 5.6 nM).

  • LM22B-10

    LM22B-10 is an activator of TrkB/TrkC neurotrophin receptor and can induce TrkB, TrkC, ERK and AKT activation in vitro and in vivo.

  • Mitapivat

    Mitapivat, also known as PKM2 activator 1020 is a PKM2 activator (pyruvate kinase activator) for the treatment of pyruvate kinase deficiency.